Impact of pure desmoplastic histological growth patterns in colorectal liver metastasis
Authors:
Open Access
- 18 December 2024
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 24 (1) , 1528
Abstract
Background Colorectal cancer (CRC) has increasingly come into worldwide cancer and almost half of patients have liver metastasis (CRLM) during the progression. Therefore, treatment of colorectal cancer liver metastasis (CRLM) is important to improve the prognosis of CRC patients. Histopathological growth patterns (HGPs) of CRLM have emerged as a reliable prognostic marker. In this study, we investigated the role of prognostic impact of pure desmoplastic HGPs (dHGPs), 100% desmoplastic, in CRLM. Methods The present study evaluated the HGPs in 71 patients with CRLM who underwent surgery (R0) between 1995 and 2012. HGPs were classified by international consensus guidelines with H&E stained slides. The pure dHGPs was defined as a complete peripheral fibrotic rim around the tumor. Results The dHGP was present in 36.6% (n = 26) and the pure-dHGPs was present in 73% (n = 19) among dHGPs patients. Pure-dHGPs were significantly associated with sex (male), metachronous metastatic period, normal CEA level, shallow tumor invasion and less lymph node metastasis. Patients with dHGPs had longer overall survival (OS) compared to other HGPs (p < 0.05). Furthermore, pure dHGPs patients had longer OS than non-pure dHGPs (90.9% vs. 51.4%, p < 0.05). Multivariate analysis identified pure dHGPs (p = 0.04) and better primary tumor differentiation (p < 0.001) were identified as independent prognostic indicators for OS. Patients with pure dHGPs also had longer disease-free survival (DFS) compared to other HGPs (p < 0.05). Pure-dHGPs patients had longer DFS than non-pure dHGPs (63.4% vs. 28.8%, p < 0.05). Multivariate analysis identified pure dHGPs (p = 0.04) and better primary tumor differentiation (p = 0.03) as independent prognostic indicators. Conclusions Pure desmoplastic HGP might be a good prognostic marker in CRLM.Keywords
This publication has 14 references indexed in Scilit:
- Histopathological growth patterns as biomarker for adjuvant systemic chemotherapy in patients with resected colorectal liver metastasesClinical & Experimental Metastasis, 2020
- Immune phenotype and histopathological growth pattern in patients with colorectal liver metastasesBritish Journal of Cancer, 2020
- Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastasesAngiogenesis, 2019
- Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti‐angiogenic therapiesThe Journal of Pathology: Clinical Research, 2018
- International consensus guidelines for scoring the histopathological growth patterns of liver metastasisBritish Journal of Cancer, 2017
- Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastasesNature Medicine, 2016
- Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensusCancer Treatment Reviews, 2015
- Prognosis according to histochemical analysis of liver metastases removed at liver resectionBritish Journal of Surgery, 2014
- Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxiaBritish Journal of Cancer, 2004
- Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasiaThe Journal of Pathology, 2001